MARKET

NAMS

NAMS

NewAmsterdam Pharma Company N.V
NASDAQ
20.14
+0.17
+0.85%
After Hours: 20.14 0 0.00% 16:15 11/13 EST
OPEN
19.93
PREV CLOSE
19.97
HIGH
20.62
LOW
19.48
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
42.21
52 WEEK LOW
17.90
MARKET CAP
2.42B
P/E (TTM)
-11.9710
1D
5D
1M
3M
1Y
5Y
1D
NewAmsterdam Pharma Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 2d ago
NewAmsterdam Pharma price target raised to $61 from $52 at Cantor Fitzgerald
TipRanks · 2d ago
Cantor Fitzgerald Maintains Overweight on NewAmsterdam Pharma Co, Raises Price Target to $61
Benzinga · 2d ago
Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Helus Pharma (HELP)
TipRanks · 4d ago
Piper Sandler Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)
TipRanks · 4d ago
Weekly Report: what happened at NAMS last week (1102-1106)?
Weekly Report · 4d ago
NewAmsterdam’s European Approvals and Pipeline Progress Support Buy Rating; $52 Price Target Unchanged
TipRanks · 11/06 13:58
NewAmsterdam Pharma Is Maintained at Buy by Needham
Dow Jones · 11/05 21:43
More
About NAMS
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMS stock methods without spending real money on the virtual paper trading platform.